出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/05/19 06:09:35」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • l-Cysteine capped Mn-doped ZnS quantum dots as a room temperature phosphorescence sensor for in-vitro binding assay of idarubicin and DNA.
  • Ertas N1, Satana Kara HE2.
  • Biosensors & bioelectronics.Biosens Bioelectron.2015 Aug 15;70:345-50. doi: 10.1016/j.bios.2015.03.055. Epub 2015 Mar 24.
  • l-cysteine capped Mn doped ZnS quantum dots/ Idarubicin (IDA) nanohybrids were used as novel room temperature phosphorescence (RTP) sensor to detect double stranded deoxyribonucleic acid (ds-DNA)/drug interaction. IDA, anthracycline derivative anticancer drug, was adsorbed on the surface of the QDs
  • PMID 25840021
  • All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
  • Sanz MA1, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vellenga E, Holowiecka A, González-Huerta AJ, Fernández P, De la Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM; IC-APL and PETHEMA and HOVON Groups.
  • Annals of hematology.Ann Hematol.2015 Aug;94(8):1347-56. doi: 10.1007/s00277-015-2393-0. Epub 2015 May 15.
  • Front-line treatment of acute promyelocytic leukaemia (APL) consists of all-trans retinoic acid (ATRA) and anthracycline-based chemotherapy. In this setting, a comparison of idarubicin and daunorubicin has never been carried out. Two similar clinical trials using ATRA and chemotherapy for newly diag
  • PMID 25975975
  • Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia.
  • Sanz MA1, Montesinos P, Casale MF, Díaz-Mediavilla J, Jiménez S, Fernández I, Fernández P, González-Campos J, González JD, Herrera P, de Lisa E, Olave T, Rojas R, Salamero O, Sayas MJ, Pellicer A, Perales A.
  • Annals of hematology.Ann Hematol.2015 Aug;94(8):1357-61. doi: 10.1007/s00277-015-2372-5. Epub 2015 Apr 25.
  • The management of pregnant women with acute promyelocytic leukemia (APL) is a challenge with limited evidence-based information available. We are reporting a series of 14 consecutive pregnant women with APL who were registered in the PETHEMA Data Centre between 1996 and 2012. APL was diagnosed durin
  • PMID 25911134


  • 急性骨髄性白血病の寛解導入療法におけるイダルビシンvs.ダウノルビシン
  • 初発時に中枢神経浸潤を合併した急性前骨髄球性白血病
  • 櫻井 環,黒田 裕行,山田 充子,在原 洋平,定免 渉,平子 匡,安部 智之,藤井 重之,前田 征洋,藤田 美悧,加藤 淳二
  • 臨床血液 54(6), 574-578, 2013
  • 急性前骨髄球性白血病(APL)の初発時に中枢神経系(CNS)浸潤を伴うことはまれである。症例は58歳,男性で2010年3月に動悸・息切れ・高熱・羞明・意識障害のため入院となった。骨髄像と染色体分析からAPLと診断した。頭部MRIで多発する高信号領域と脳脊髄液細胞診でAPL細胞を認め,APLのCNS浸潤と判断された。All-trans retinoic acidと全身化学療法を行い,地固め療法終了後 …
  • NAID 130004501824
  • sorafenib で寛解に至った初期治療抵抗性FLT3-ITD陽性急性単芽球性白血病
  • 高橋 憲幸,川上 貴子,佐藤 裕子 [他],小野田 正志,簡野 美弥子,三井 哲夫,早坂 清
  • 臨床血液 53(11), 1932-1936, 2012-11-30
  • 症例は6歳男児。FLT3-ITD陽性急性単芽球性白血病(AMoL)と診断,日本小児白血病リンパ腫研究グループAML-05寛解導入で寛解に至らなかった。救済療法でも寛解に至らず,骨髄回復期にsorafenibを200 mg/日で開始,300 mg/日に増量,10日後寛解を得た。29日間内服後,HLA 2座不一致骨髄移植を施行。移植後71日目に骨髄再発,150mg/日を隔日投与で再開,部分寛解を得た。 …
  • NAID 10031131262


Synopsis Idarubicin is a 4-demethoxy-anthracycline analogue of daunorubicin which, when administered intravenously in combination withcytarabine,hastherapeutic efficacy superior to that of standard induction and salvage treatment ...
What is the most important information I should know about idarubicin? Idarubicin should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents. Serious ...
Idarubicin is a cancer (antineoplastic) medication. Idarubicin interferes with the growth of cancer cells and slows their growth and spread in the body. Idarubicin is used to treat a type of blood cancer (acute myeloid leukemia -AML) in ...


Idarubicin – Generic, Idamycin®Idarubicin hydrochlorideIdarubicinLGM Pharma is a Idarubicin 58957-92-9 Description Idarubicin2.svgIdarubicin.svg

拡張検索idarubicin hydrochloride



anthracycline, anthracyclines




idarubicin, IDR, IDAR
イダマイシン Idamycin
塩酸イダルビシン idarubicin hydrochloride

  • 抗悪性腫瘍薬、アントラサイクリン系抗生物質


  [★] イダルビシン idarubicin

idarubicin hydrochloride」